Radioiodine News and Research

RSS

Iodine-131 (131I), also called radioiodine (though many other radioactive isotopes of this element are known), is an important radioisotope of iodine. It has a radioactive decay half life of about eight days. Its uses are mostly medical and pharmaceutical.

Hopkins discovery provides molecular marker to assess risk for patients with papillary thyroid cancer

Scientists at Johns Hopkins have found that a mutation in the gene that triggers production of a tumor growth protein is linked to poorer outcomes for patients with papillary thyroid cancer (PTC).

6 Jan 2006

New treatment advances for patients with follicular lymphoma

A newly published study recommends that doctors carefully choose their patients' initial therapies because there are significant differences in overall survival rates, according to researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center.

20 Oct 2005

Chernobyl: The True Scale of the Accident

A total of up to four thousand people could eventually die of radiation exposure from the Chernobyl nuclear power plant (NPP) accident nearly 20 years ago, an international team of more than 100 scientists has concluded.

5 Sep 2005

New discoveries in treatment for patients with non-Hodgkin's lymphoma

Three scientific studies - each highlighting new discoveries in treatment for patients with non-Hodgkin's lymphoma - were announced at the Society of Nuclear Medicine's 52nd Annual Meeting June 18–22 in Toronto.

20 Jun 2005

Exposure to radioactive iodines in childhood is associated with an increased risk of thyroid cancer

Exposure to radioactive iodines, mainly iodine 131 (I-131), in childhood is associated with an increased risk of thyroid cancer. Importantly, both iodine deficiency and supplementation appear to modify this risk, according to a new study in the May 18 issue of the Journal of the National Cancer Institute.

17 May 2005

Researchers study radiation blockers while conducting nuclear imaging of Iodine uptake in mouse tissues

Scientists have found that a dose five times higher than the FDA-recommended dosage of potassium iodide in the event of a nuclear accident is needed to protect small animals effectively from radioactive iodide in medical imaging procedures. The long-term animal nuclear imaging project is being conducted by a collaboration of biology and physics researchers from the Department of Energy's Jefferson Lab and The College of William & Mary (CWM).

20 Apr 2005

GlaxoSmithKline acquires full marketing and development rights for BEXXAR worldwide

GlaxoSmithKline announced that it has reached an agreement with Corixa Corporation to acquire worldwide rights and responsibilities related to the manufacturing, development and commercialization of the BEXXAR® therapeutic regimen.

14 Dec 2004

Risk of thyroid cancer rises with increasing radiation dose

The risk of thyroid cancer rises with increasing radiation dose, according to the most thorough risk analysis for thyroid cancer to date among people who grew up in the shadow of the 1986 Chernobyl power-plant disaster.

2 Sep 2004

Genetically engineered thyroid stimulating hormone destroys tissue that often remains after thyroidectomy

A new approach to therapy can avoid most of the debilitating effects of preparing for critical, postsurgical treatment for patients with thyroid cancer, according to an international study led by researchers from Johns Hopkins and the University of Pisa.

16 Jun 2004